Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1987 May;55(5):1058-62.
doi: 10.1128/iai.55.5.1058-1062.1987.

Serum-mediated suppression of lymphocyte transformation responses in coccidioidomycosis

Serum-mediated suppression of lymphocyte transformation responses in coccidioidomycosis

R A Cox et al. Infect Immun. 1987 May.

Abstract

Lymphocyte transformation (LT) responses to coccidioidin (CDN) and spherulin were suppressed in 11 (73%) of 15 patients with active coccidioidomycosis when their mononuclear cells were assayed in autologous serum as compared to serum from healthy, CDN skin test-positive subjects. Suppressed LT responses were specific for Coccidioides immitis antigens in 7 (64%) of the 11 patients. Immunoaffinity chromatography of patient sera with Staphylococcus protein A adsorbed the suppressor component(s) and thereby established that suppression was attributed to immunoglobulin G, either alone or complexed with antigen. The possibility that suppression was mediated by immune complexes was examined by adding complexes formed in vivo or in vitro to mononuclear cell cultures of healthy CDN-reactive persons before LT assays. Although complexes prepared in this manner were reactive in an enzyme-linked immunosorbent assay designed to detect Coccidioides antigen-specific immune complexes, no suppression of LT responses was observed. We conclude that serum-mediated suppression of LT responses in coccidioidomycosis is attributed to monomeric and not immune-complexed immunoglobulin G antibody.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am Rev Respir Dis. 1981 Jun;123(6):665-9 - PubMed
    1. J Clin Invest. 1980 Oct;66(4):655-63 - PubMed
    1. Am Rev Respir Dis. 1982 Sep;126(3):439-43 - PubMed
    1. J Immunol. 1984 Oct;133(4):1846-51 - PubMed
    1. Infect Immun. 1985 Nov;50(2):343-53 - PubMed

Publication types

MeSH terms